BlackRock, Inc. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
11,210,671 6.700% |
0 (Unchanged) |
Filing |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
11,210,671 6.700% |
3,049,924 (+37.37%) |
Filing |
| 2024-02-07 5:09 pm Sale |
2024-01-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
8,160,747 4.900% |
-256,777 (-3.05%) |
Filing |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
8,417,524 5.000% |
7,343,033 (+683.40%) |
Filing |
| 2021-05-07 5:09 pm Purchase |
2021-04-30 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
1,074,491 4.500% |
40,988 (+3.97%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
BlackRock Inc. BLK |
1,033,503 6.300% |
1,033,503 (New Position) |
Filing |